
News|Articles|May 8, 2024
Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD
Author(s)Peter J. Weiden, MD, John J. Miller, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the
Dr Weiden is a professor at the State University of New York at Stony Brook.
See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults
3
Psychiatric Pharmacogenomics: An Overview
4
Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint
5











